Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase
g-Secretase inhibitors recently or currently in clinical trials for the... | Download Scientific Diagram
γ-Secretase inhibitors repress thymocyte development | PNAS
Frontiers | DAPT, a γ-Secretase Inhibitor, Suppresses Tumorigenesis, and Progression of Growth Hormone-Producing Adenomas by Targeting Notch Signaling | Oncology
Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase
Semagacestat Is a Pseudo-Inhibitor of γ-Secretase - ScienceDirect
γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment - ScienceDirect
γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct | EMBO Molecular Medicine
Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease - Clinical Trials Arena
RO4929097 | ≥99%(HPLC) | Selleck | Gamma-secretase inhibitor
Targeting gamma secretase: has progress moved up a Notch? - Annals of Oncology
g-Secretase inhibitors in clinical development for the treatment of... | Download Table
γ-Secretase inhibitors for breast cancer and hepatocellular carcinoma: From mechanism to treatment - ScienceDirect
γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct | EMBO Molecular Medicine
Pharmaceuticals | Free Full-Text | BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease | HTML
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead - ScienceDirect
γ-secretase inhibitors: Notch so bad | Nature Medicine
Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease - Clinical Trials Arena
PDF) Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS-708163 in patients with mild-to-moderate AD | Mark Meadowcroft and charles e albright -
Gamma-secretase Inhibition | Gamma-secretase Inhibitor Review
Clinical trials employing γ-secretase inhibitors in the treatment of... | Download Scientific Diagram
Clinical trials employing γ-secretase inhibitors in the treatment of... | Download Table
Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio | Cell Discovery
Frontiers | Targeting Amyloidogenic Processing of APP in Alzheimer's Disease | Molecular Neuroscience
